CDK12 and cancer: In the pan‐cancer analysis by Sokol et al., CDK12‐loss‐of‐function was associated with an increased focal tandem duplication burden in all evaluated malignancy subtypes including gastrointestinal, gynecologic, and cancer of unknown primary.